ROYAL BANK OF CANADA - KYMERA THERAPEUTICS INC ownership

KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 103 filers reported holding KYMERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of KYMERA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$66,000
+3.1%
4,758
+71.6%
0.00%
Q2 2023$64,000
+1.6%
2,773
+30.0%
0.00%
Q1 2023$63,000
-53.7%
2,133
-60.8%
0.00%
Q4 2022$136,000
+1260.0%
5,435
+1081.5%
0.00%
Q3 2022$10,000
+150.0%
460
+116.0%
0.00%
Q2 2022$4,000
-95.6%
213
-90.1%
0.00%
Q1 2022$90,000
-81.6%
2,142
-72.2%
0.00%
Q4 2021$490,000
+134.4%
7,715
+116.9%
0.00%
Q3 2021$209,000
-15.4%
3,557
-30.2%
0.00%
Q2 2021$247,000
+177.5%
5,097
+123.4%
0.00%
Q1 2021$89,000
+790.0%
2,282
+1326.2%
0.00%
Q4 2020$10,0001600.00%
Other shareholders
KYMERA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Deer IX & Co. Ltd. 1,755,356$97,949,00048.97%
Trustees of Columbia University in the City of New York 463,298$28,724,00038.38%
AJU IB Investment Co., Ltd. 704,059$43,652,00016.52%
BVF INC/IL 2,630,658$163,101,0006.42%
Redmile Group, LLC 2,720,489$168,670,0002.04%
Bain Capital Life Sciences Investors, LLC 479,605$29,735,0001.87%
Rock Springs Capital Management LP 713,865$44,260,0000.94%
SPHERA FUNDS MANAGEMENT LTD. 147,700$9,157,0000.81%
HighVista Strategies LLC 17,117$1,061,0000.68%
Logos Global Management LP 110,920$6,877,0000.59%
View complete list of KYMERA THERAPEUTICS INC shareholders